These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Dose-dependent effect of rosuvastatin treatment on HDL-subfraction phenotype in patients with primary hyperlipidemia. Kostapanos MS; Milionis HJ; Filippatos TD; Christogiannis LG; Bairaktari ET; Tselepis AD; Elisaf MS J Cardiovasc Pharmacol Ther; 2009 Mar; 14(1):5-13. PubMed ID: 19246334 [TBL] [Abstract][Full Text] [Related]
7. Effect of rosuvastatin on C-reactive protein and renal function in patients with chronic kidney disease. Verma A; Ranganna KM; Reddy RS; Verma M; Gordon NF Am J Cardiol; 2005 Nov; 96(9):1290-2. PubMed ID: 16253600 [TBL] [Abstract][Full Text] [Related]
8. α1-Microglobulin/albumin ratio may improve interpretation of albuminuria in statin-treated patients. Wehlou CM; Speeckaert MM; Fiers T; De Buyzere ML; Delanghe JR Clin Chem Lab Med; 2013 Jul; 51(7):1529-34. PubMed ID: 23314557 [TBL] [Abstract][Full Text] [Related]
9. Rosuvastatin treatment is associated with an increase in insulin resistance in hyperlipidaemic patients with impaired fasting glucose. Kostapanos MS; Milionis HJ; Agouridis AD; Rizos CV; Elisaf MS Int J Clin Pract; 2009 Sep; 63(9):1308-13. PubMed ID: 19691613 [TBL] [Abstract][Full Text] [Related]
10. Effectiveness and tolerability of every-other-day rosuvastatin dosing in patients with prior statin intolerance. Backes JM; Venero CV; Gibson CA; Ruisinger JF; Howard PA; Thompson PD; Moriarty PM Ann Pharmacother; 2008 Mar; 42(3):341-6. PubMed ID: 18285559 [TBL] [Abstract][Full Text] [Related]
11. Baseline triglyceride levels and insulin sensitivity are major determinants of the increase of LDL particle size and buoyancy induced by rosuvastatin treatment in patients with primary hyperlipidemia. Kostapanos MS; Milionis HJ; Lagos KG; Rizos CB; Tselepis AD; Elisaf MS Eur J Pharmacol; 2008 Aug; 590(1-3):327-32. PubMed ID: 18585701 [TBL] [Abstract][Full Text] [Related]
12. Effect of short-term rosuvastatin treatment on estimated glomerular filtration rate. Vidt DG; Harris S; McTaggart F; Ditmarsch M; Sager PT; Sorof JM Am J Cardiol; 2006 Jun; 97(11):1602-6. PubMed ID: 16728222 [TBL] [Abstract][Full Text] [Related]
13. Effect of rosuvastatin on warfarin pharmacodynamics and pharmacokinetics. Simonson SG; Martin PD; Mitchell PD; Lasseter K; Gibson G; Schneck DW J Clin Pharmacol; 2005 Aug; 45(8):927-34. PubMed ID: 16027403 [TBL] [Abstract][Full Text] [Related]
14. Rosuvastatin (Crestor) and rhabdomyolysis. Wooltorton E CMAJ; 2004 Jul; 171(2):129. PubMed ID: 15262879 [No Abstract] [Full Text] [Related]
15. Safety of rosuvastatin: update on 16,876 rosuvastatin-treated patients in a multinational clinical trial program. Shepherd J; Vidt DG; Miller E; Harris S; Blasetto J Cardiology; 2007; 107(4):433-43. PubMed ID: 17363845 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of rosuvastatin and atorvastatin when force-titrated in patients with primary hypercholesterolemia: results from the ECLIPSE study. Faergeman O; Hill L; Windler E; Wiklund O; Asmar R; Duffield E; Sosef F; Cardiology; 2008; 111(4):219-28. PubMed ID: 18434729 [TBL] [Abstract][Full Text] [Related]
17. Alternate day rosuvastatin, an underutilized option in statin intolerant hyperlipidemic patients: a case report and literature review. Gopalagowda BH; Cutchins C; Cutchins DC; Peiris AN Tenn Med; 2011 Feb; 104(2):49-51. PubMed ID: 21387899 [TBL] [Abstract][Full Text] [Related]
18. Rosuvastatin does not affect intrarenal hemodynamics in patients with hypercholesterolemia. Ott C; Ritt M; Titze SI; Schäufele T; Schmieder RE J Nephrol; 2009; 22(5):675-81. PubMed ID: 19810001 [TBL] [Abstract][Full Text] [Related]
19. Rosuvastatin, but not simvastatin, provides end-organ protection in stroke-prone rats by antiinflammatory effects. Sironi L; Gianazza E; Gelosa P; Guerrini U; Nobili E; Gianella A; Cremonesi B; Paoletti R; Tremoli E Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):598-603. PubMed ID: 15681303 [TBL] [Abstract][Full Text] [Related]
20. Effect of rosuvastatin or atorvastatin on urinary albumin excretion and renal function in type 2 diabetic patients. Sorof J; Berne C; Siewert-Delle A; Jørgensen L; Sager P; Diabetes Res Clin Pract; 2006 Apr; 72(1):81-7. PubMed ID: 16246447 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]